Dr. Alexander Pearson, MD
Claim this profileUniversity of Chicago
Studies Squamous Cell Carcinoma
Studies Cancer
5 reported clinical trials
9 drugs studied
Area of expertise
1Squamous Cell Carcinoma
HPV positive
Stage IV
PD-L1 positive
2Cancer
Stage IV
HPV 16 positive
Affiliated Hospitals
Clinical Trials Alexander Pearson, MD is currently running
SBRT
for Adenoid Cystic Carcinoma
The aim of this study is to learn whether the early initiation of a specialized and focused type of radiation called stereotactic body radiation therapy (SBRT) will impact the progression of advanced adenoid cystic carcinoma, quality of life, and overall survival. The name(s) of the study intervention involved in this study is: * Stereotactic Body Radiation Therapy (SBRT)
Recruiting1 award N/A13 criteria
T-DM1 + Chemoradiation
for Salivary Gland Cancer
This trial is testing a special drug called T-DM1 combined with regular cancer treatments in patients with HER2-positive salivary gland cancer. The drug targets cancer cells specifically and delivers chemotherapy directly to them. The goal is to see if this combination is safe and effective in preventing cancer recurrence. T-DM1 has shown effectiveness in treating HER2-positive cancers, including breast and salivary gland cancers, by targeting cancer cells and delivering chemotherapy directly to them.
Recruiting1 award Phase 221 criteria
More about Alexander Pearson, MD
Clinical Trial Related3 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Alexander Pearson, MD has experience with
- Pembrolizumab
- Placebo
- HB-201
- HB-202
- Docetaxel
- Ado-trastuzumab Emtansine (T-DM1)
Breakdown of trials Alexander Pearson, MD has run
Squamous Cell Carcinoma
Salivary Gland Cancer
Head and Neck Cancers
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alexander Pearson, MD specialize in?
Alexander Pearson, MD focuses on Squamous Cell Carcinoma and Cancer. In particular, much of their work with Squamous Cell Carcinoma has involved HPV positive patients, or patients who are Stage IV.
Is Alexander Pearson, MD currently recruiting for clinical trials?
Yes, Alexander Pearson, MD is currently recruiting for 2 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Alexander Pearson, MD has studied deeply?
Yes, Alexander Pearson, MD has studied treatments such as Pembrolizumab, Placebo, HB-201.
What is the best way to schedule an appointment with Alexander Pearson, MD?
Apply for one of the trials that Alexander Pearson, MD is conducting.
What is the office address of Alexander Pearson, MD?
The office of Alexander Pearson, MD is located at: University of Chicago, Chicago, Illinois 60637 United States. This is the address for their practice at the University of Chicago.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.